Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)

Needs review: award amount not stated in source data

Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) is a funding call from National Institutes of Health that closes 26 May 2028. Funding: not stated in source data — see the official call. Eligibility: NIH-style eligibility: US institutions only; non-US (foreign) organisations are not eligible to apply.

Funder: National Institutes of Health
Deadline: 26 May 2028 (589 days)
Amount: Not stated in source data — see call
Region / eligibility: United States
Career stage: early-career, established / PI
Fields: chemistry
Reference: PAR-26-121
Official call: Grants.gov listing

Eligibility in plain language

NIH-style eligibility: US institutions only; non-US (foreign) organisations are not eligible to apply.

Who should apply

Synthetic, physical and analytical chemists — best fit for postdocs and early-career researchers or PIs and research groups.

Summary from source

The Maximizing Investigators' Research Award (MIRA) provides support for individual investigators for research within the scientific mission of NIGMS via a single grant to achieve the following:Increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively;Increase flexibility for investigators to follow important new research directions within the NIGMS mission as opportunities arise, rather than being bound to specific aims proposed in advance of the studies;More widely distribute funding among the nation's highly talented and promising investigators to increase overall scientific productivity and the chances for important breakthroughs;Reduce the time spent by researchers writing and reviewing grant applications, allowing them to spend more time conducting research;Re…

Raw eligibility text

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.